カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の関節炎治療用処方薬市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Prescription Arthritis Medications Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19563）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19563
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：93
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の関節炎治療用処方薬市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

関節炎治療用処方薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の関節炎治療用処方薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

関節炎治療用処方薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・経口、外用

用途別セグメントは次のように区分されます。
・病院薬局、オンライン薬局、リテール薬局

世界の関節炎治療用処方薬市場の主要な市場プレーヤーは以下のとおりです。
・Abbott、Amgen、Boehringer Ingelheim、Horizon Pharma、Novartis、Pfizer、Regeneron

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、関節炎治療用処方薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な関節炎治療用処方薬メーカーの企業概要、2019年～2022年までの関節炎治療用処方薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な関節炎治療用処方薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別関節炎治療用処方薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの関節炎治療用処方薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での関節炎治療用処方薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および関節炎治療用処方薬の産業チェーンを掲載しています。
・第13、14、15章では、関節炎治療用処方薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 関節炎治療用処方薬の概要
- 種類別分析（2017年vs2021年vs2028年）：経口、外用
- 用途別分析（2017年vs2021年vs2028年）：病院薬局、オンライン薬局、リテール薬局
- 世界の関節炎治療用処方薬市場規模・予測
- 世界の関節炎治療用処方薬生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Abbott、Amgen、Boehringer Ingelheim、Horizon Pharma、Novartis、Pfizer、Regeneron
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：経口、外用
・用途別分析2017年-2028年：病院薬局、オンライン薬局、リテール薬局
・関節炎治療用処方薬の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・関節炎治療用処方薬のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・関節炎治療用処方薬のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・関節炎治療用処方薬の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・関節炎治療用処方薬の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Prescription Arthritis Medications market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Prescription Arthritis Medications market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital Pharmacies accounting for % of the Prescription Arthritis Medications global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Oral segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Prescription Arthritis Medications include Abbott, Amgen, Boehringer Ingelheim, Horizon Pharma, and Novartis, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Prescription Arthritis Medications market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oral
Topical
Market segment by Application can be divided into
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
The key market players for global Prescription Arthritis Medications market are listed below:
Abbott
Amgen
Boehringer Ingelheim
Horizon Pharma
Novartis
Pfizer
Regeneron
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Prescription Arthritis Medications product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Prescription Arthritis Medications, with price, sales, revenue and global market share of Prescription Arthritis Medications from 2019 to 2022.
Chapter 3, the Prescription Arthritis Medications competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prescription Arthritis Medications breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Prescription Arthritis Medications market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Prescription Arthritis Medications.
Chapter 13, 14, and 15, to describe Prescription Arthritis Medications sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Prescription Arthritis Medications Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Prescription Arthritis Medications Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Oral
1.2.3 Topical
1.3 Market Analysis by Application
1.3.1 Overview: Global Prescription Arthritis Medications Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Global Prescription Arthritis Medications Market Size & Forecast
1.4.1 Global Prescription Arthritis Medications Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Prescription Arthritis Medications Sales in Volume (2017-2028)
1.4.3 Global Prescription Arthritis Medications Price (2017-2028)
1.5 Global Prescription Arthritis Medications Production Capacity Analysis
1.5.1 Global Prescription Arthritis Medications Total Production Capacity (2017-2028)
1.5.2 Global Prescription Arthritis Medications Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Prescription Arthritis Medications Market Drivers
1.6.2 Prescription Arthritis Medications Market Restraints
1.6.3 Prescription Arthritis Medications Trends Analysis
2 Manufacturers Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Prescription Arthritis Medications Product and Services
2.1.4 Abbott Prescription Arthritis Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Prescription Arthritis Medications Product and Services
2.2.4 Amgen Prescription Arthritis Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Boehringer Ingelheim
2.3.1 Boehringer Ingelheim Details
2.3.2 Boehringer Ingelheim Major Business
2.3.3 Boehringer Ingelheim Prescription Arthritis Medications Product and Services
2.3.4 Boehringer Ingelheim Prescription Arthritis Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Horizon Pharma
2.4.1 Horizon Pharma Details
2.4.2 Horizon Pharma Major Business
2.4.3 Horizon Pharma Prescription Arthritis Medications Product and Services
2.4.4 Horizon Pharma Prescription Arthritis Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis Prescription Arthritis Medications Product and Services
2.5.4 Novartis Prescription Arthritis Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Prescription Arthritis Medications Product and Services
2.6.4 Pfizer Prescription Arthritis Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Regeneron
2.7.1 Regeneron Details
2.7.2 Regeneron Major Business
2.7.3 Regeneron Prescription Arthritis Medications Product and Services
2.7.4 Regeneron Prescription Arthritis Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Prescription Arthritis Medications Breakdown Data by Manufacturer
3.1 Global Prescription Arthritis Medications Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Prescription Arthritis Medications Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Prescription Arthritis Medications
3.4 Market Concentration Rate
3.4.1 Top 3 Prescription Arthritis Medications Manufacturer Market Share in 2021
3.4.2 Top 6 Prescription Arthritis Medications Manufacturer Market Share in 2021
3.5 Global Prescription Arthritis Medications Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Prescription Arthritis Medications Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Prescription Arthritis Medications Market Size by Region
4.1.1 Global Prescription Arthritis Medications Sales in Volume by Region (2017-2028)
4.1.2 Global Prescription Arthritis Medications Revenue by Region (2017-2028)
4.2 North America Prescription Arthritis Medications Revenue (2017-2028)
4.3 Europe Prescription Arthritis Medications Revenue (2017-2028)
4.4 Asia-Pacific Prescription Arthritis Medications Revenue (2017-2028)
4.5 South America Prescription Arthritis Medications Revenue (2017-2028)
4.6 Middle East and Africa Prescription Arthritis Medications Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Prescription Arthritis Medications Sales in Volume by Type (2017-2028)
5.2 Global Prescription Arthritis Medications Revenue by Type (2017-2028)
5.3 Global Prescription Arthritis Medications Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Prescription Arthritis Medications Sales in Volume by Application (2017-2028)
6.2 Global Prescription Arthritis Medications Revenue by Application (2017-2028)
6.3 Global Prescription Arthritis Medications Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Prescription Arthritis Medications Sales by Type (2017-2028)
7.2 North America Prescription Arthritis Medications Sales by Application (2017-2028)
7.3 North America Prescription Arthritis Medications Market Size by Country
7.3.1 North America Prescription Arthritis Medications Sales in Volume by Country (2017-2028)
7.3.2 North America Prescription Arthritis Medications Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Prescription Arthritis Medications Sales by Type (2017-2028)
8.2 Europe Prescription Arthritis Medications Sales by Application (2017-2028)
8.3 Europe Prescription Arthritis Medications Market Size by Country
8.3.1 Europe Prescription Arthritis Medications Sales in Volume by Country (2017-2028)
8.3.2 Europe Prescription Arthritis Medications Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Prescription Arthritis Medications Sales by Type (2017-2028)
9.2 Asia-Pacific Prescription Arthritis Medications Sales by Application (2017-2028)
9.3 Asia-Pacific Prescription Arthritis Medications Market Size by Region
9.3.1 Asia-Pacific Prescription Arthritis Medications Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Prescription Arthritis Medications Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Prescription Arthritis Medications Sales by Type (2017-2028)
10.2 South America Prescription Arthritis Medications Sales by Application (2017-2028)
10.3 South America Prescription Arthritis Medications Market Size by Country
10.3.1 South America Prescription Arthritis Medications Sales in Volume by Country (2017-2028)
10.3.2 South America Prescription Arthritis Medications Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Prescription Arthritis Medications Sales by Type (2017-2028)
11.2 Middle East & Africa Prescription Arthritis Medications Sales by Application (2017-2028)
11.3 Middle East & Africa Prescription Arthritis Medications Market Size by Country
11.3.1 Middle East & Africa Prescription Arthritis Medications Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Prescription Arthritis Medications Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Prescription Arthritis Medications and Key Manufacturers
12.2 Manufacturing Costs Percentage of Prescription Arthritis Medications
12.3 Prescription Arthritis Medications Production Process
12.4 Prescription Arthritis Medications Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Prescription Arthritis Medications Typical Distributors
13.3 Prescription Arthritis Medications Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Prescription Arthritis Medications Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Prescription Arthritis Medications Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Abbott Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Major Business
Table 5. Abbott Prescription Arthritis Medications Product and Services
Table 6. Abbott Prescription Arthritis Medications Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Amgen Basic Information, Manufacturing Base and Competitors
Table 8. Amgen Major Business
Table 9. Amgen Prescription Arthritis Medications Product and Services
Table 10. Amgen Prescription Arthritis Medications Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 12. Boehringer Ingelheim Major Business
Table 13. Boehringer Ingelheim Prescription Arthritis Medications Product and Services
Table 14. Boehringer Ingelheim Prescription Arthritis Medications Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Horizon Pharma Basic Information, Manufacturing Base and Competitors
Table 16. Horizon Pharma Major Business
Table 17. Horizon Pharma Prescription Arthritis Medications Product and Services
Table 18. Horizon Pharma Prescription Arthritis Medications Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Novartis Basic Information, Manufacturing Base and Competitors
Table 20. Novartis Major Business
Table 21. Novartis Prescription Arthritis Medications Product and Services
Table 22. Novartis Prescription Arthritis Medications Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Pfizer Basic Information, Manufacturing Base and Competitors
Table 24. Pfizer Major Business
Table 25. Pfizer Prescription Arthritis Medications Product and Services
Table 26. Pfizer Prescription Arthritis Medications Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Regeneron Basic Information, Manufacturing Base and Competitors
Table 28. Regeneron Major Business
Table 29. Regeneron Prescription Arthritis Medications Product and Services
Table 30. Regeneron Prescription Arthritis Medications Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Global Prescription Arthritis Medications Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 32. Global Prescription Arthritis Medications Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 33. Market Position of Manufacturers in Prescription Arthritis Medications, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 34. Global Prescription Arthritis Medications Production Capacity by Company, (K Units): 2020 VS 2021
Table 35. Head Office and Prescription Arthritis Medications Production Site of Key Manufacturer
Table 36. Prescription Arthritis Medications New Entrant and Capacity Expansion Plans
Table 37. Prescription Arthritis Medications Mergers & Acquisitions in the Past Five Years
Table 38. Global Prescription Arthritis Medications Sales by Region (2017-2022) & (K Units)
Table 39. Global Prescription Arthritis Medications Sales by Region (2023-2028) & (K Units)
Table 40. Global Prescription Arthritis Medications Revenue by Region (2017-2022) & (USD Million)
Table 41. Global Prescription Arthritis Medications Revenue by Region (2023-2028) & (USD Million)
Table 42. Global Prescription Arthritis Medications Sales by Type (2017-2022) & (K Units)
Table 43. Global Prescription Arthritis Medications Sales by Type (2023-2028) & (K Units)
Table 44. Global Prescription Arthritis Medications Revenue by Type (2017-2022) & (USD Million)
Table 45. Global Prescription Arthritis Medications Revenue by Type (2023-2028) & (USD Million)
Table 46. Global Prescription Arthritis Medications Price by Type (2017-2022) & (USD/Unit)
Table 47. Global Prescription Arthritis Medications Price by Type (2023-2028) & (USD/Unit)
Table 48. Global Prescription Arthritis Medications Sales by Application (2017-2022) & (K Units)
Table 49. Global Prescription Arthritis Medications Sales by Application (2023-2028) & (K Units)
Table 50. Global Prescription Arthritis Medications Revenue by Application (2017-2022) & (USD Million)
Table 51. Global Prescription Arthritis Medications Revenue by Application (2023-2028) & (USD Million)
Table 52. Global Prescription Arthritis Medications Price by Application (2017-2022) & (USD/Unit)
Table 53. Global Prescription Arthritis Medications Price by Application (2023-2028) & (USD/Unit)
Table 54. North America Prescription Arthritis Medications Sales by Country (2017-2022) & (K Units)
Table 55. North America Prescription Arthritis Medications Sales by Country (2023-2028) & (K Units)
Table 56. North America Prescription Arthritis Medications Revenue by Country (2017-2022) & (USD Million)
Table 57. North America Prescription Arthritis Medications Revenue by Country (2023-2028) & (USD Million)
Table 58. North America Prescription Arthritis Medications Sales by Type (2017-2022) & (K Units)
Table 59. North America Prescription Arthritis Medications Sales by Type (2023-2028) & (K Units)
Table 60. North America Prescription Arthritis Medications Sales by Application (2017-2022) & (K Units)
Table 61. North America Prescription Arthritis Medications Sales by Application (2023-2028) & (K Units)
Table 62. Europe Prescription Arthritis Medications Sales by Country (2017-2022) & (K Units)
Table 63. Europe Prescription Arthritis Medications Sales by Country (2023-2028) & (K Units)
Table 64. Europe Prescription Arthritis Medications Revenue by Country (2017-2022) & (USD Million)
Table 65. Europe Prescription Arthritis Medications Revenue by Country (2023-2028) & (USD Million)
Table 66. Europe Prescription Arthritis Medications Sales by Type (2017-2022) & (K Units)
Table 67. Europe Prescription Arthritis Medications Sales by Type (2023-2028) & (K Units)
Table 68. Europe Prescription Arthritis Medications Sales by Application (2017-2022) & (K Units)
Table 69. Europe Prescription Arthritis Medications Sales by Application (2023-2028) & (K Units)
Table 70. Asia-Pacific Prescription Arthritis Medications Sales by Region (2017-2022) & (K Units)
Table 71. Asia-Pacific Prescription Arthritis Medications Sales by Region (2023-2028) & (K Units)
Table 72. Asia-Pacific Prescription Arthritis Medications Revenue by Region (2017-2022) & (USD Million)
Table 73. Asia-Pacific Prescription Arthritis Medications Revenue by Region (2023-2028) & (USD Million)
Table 74. Asia-Pacific Prescription Arthritis Medications Sales by Type (2017-2022) & (K Units)
Table 75. Asia-Pacific Prescription Arthritis Medications Sales by Type (2023-2028) & (K Units)
Table 76. Asia-Pacific Prescription Arthritis Medications Sales by Application (2017-2022) & (K Units)
Table 77. Asia-Pacific Prescription Arthritis Medications Sales by Application (2023-2028) & (K Units)
Table 78. South America Prescription Arthritis Medications Sales by Country (2017-2022) & (K Units)
Table 79. South America Prescription Arthritis Medications Sales by Country (2023-2028) & (K Units)
Table 80. South America Prescription Arthritis Medications Revenue by Country (2017-2022) & (USD Million)
Table 81. South America Prescription Arthritis Medications Revenue by Country (2023-2028) & (USD Million)
Table 82. South America Prescription Arthritis Medications Sales by Type (2017-2022) & (K Units)
Table 83. South America Prescription Arthritis Medications Sales by Type (2023-2028) & (K Units)
Table 84. South America Prescription Arthritis Medications Sales by Application (2017-2022) & (K Units)
Table 85. South America Prescription Arthritis Medications Sales by Application (2023-2028) & (K Units)
Table 86. Middle East & Africa Prescription Arthritis Medications Sales by Region (2017-2022) & (K Units)
Table 87. Middle East & Africa Prescription Arthritis Medications Sales by Region (2023-2028) & (K Units)
Table 88. Middle East & Africa Prescription Arthritis Medications Revenue by Region (2017-2022) & (USD Million)
Table 89. Middle East & Africa Prescription Arthritis Medications Revenue by Region (2023-2028) & (USD Million)
Table 90. Middle East & Africa Prescription Arthritis Medications Sales by Type (2017-2022) & (K Units)
Table 91. Middle East & Africa Prescription Arthritis Medications Sales by Type (2023-2028) & (K Units)
Table 92. Middle East & Africa Prescription Arthritis Medications Sales by Application (2017-2022) & (K Units)
Table 93. Middle East & Africa Prescription Arthritis Medications Sales by Application (2023-2028) & (K Units)
Table 94. Prescription Arthritis Medications Raw Material
Table 95. Key Manufacturers of Prescription Arthritis Medications Raw Materials
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Prescription Arthritis Medications Typical Distributors
Table 99. Prescription Arthritis Medications Typical Customers
List of Figures
Figure 1. Prescription Arthritis Medications Picture
Figure 2. Global Prescription Arthritis Medications Revenue Market Share by Type in 2021
Figure 3. Oral
Figure 4. Topical
Figure 5. Global Prescription Arthritis Medications Revenue Market Share by Application in 2021
Figure 6. Hospital Pharmacies
Figure 7. Online Pharmacies
Figure 8. Retail Pharmacies
Figure 9. Global Prescription Arthritis Medications Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Prescription Arthritis Medications Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Prescription Arthritis Medications Sales (2017-2028) & (K Units)
Figure 12. Global Prescription Arthritis Medications Price (2017-2028) & (USD/Unit)
Figure 13. Global Prescription Arthritis Medications Production Capacity (2017-2028) & (K Units)
Figure 14. Global Prescription Arthritis Medications Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Prescription Arthritis Medications Market Drivers
Figure 16. Prescription Arthritis Medications Market Restraints
Figure 17. Prescription Arthritis Medications Market Trends
Figure 18. Global Prescription Arthritis Medications Sales Market Share by Manufacturer in 2021
Figure 19. Global Prescription Arthritis Medications Revenue Market Share by Manufacturer in 2021
Figure 20. Prescription Arthritis Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Prescription Arthritis Medications Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Prescription Arthritis Medications Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Prescription Arthritis Medications Sales Market Share by Region (2017-2028)
Figure 24. Global Prescription Arthritis Medications Revenue Market Share by Region (2017-2028)
Figure 25. North America Prescription Arthritis Medications Revenue (2017-2028) & (USD Million)
Figure 26. Europe Prescription Arthritis Medications Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Prescription Arthritis Medications Revenue (2017-2028) & (USD Million)
Figure 28. South America Prescription Arthritis Medications Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Prescription Arthritis Medications Revenue (2017-2028) & (USD Million)
Figure 30. Global Prescription Arthritis Medications Sales Market Share by Type (2017-2028)
Figure 31. Global Prescription Arthritis Medications Revenue Market Share by Type (2017-2028)
Figure 32. Global Prescription Arthritis Medications Price by Type (2017-2028) & (USD/Unit)
Figure 33. Global Prescription Arthritis Medications Sales Market Share by Application (2017-2028)
Figure 34. Global Prescription Arthritis Medications Revenue Market Share by Application (2017-2028)
Figure 35. Global Prescription Arthritis Medications Price by Application (2017-2028) & (USD/Unit)
Figure 36. North America Prescription Arthritis Medications Sales Market Share by Type (2017-2028)
Figure 37. North America Prescription Arthritis Medications Sales Market Share by Application (2017-2028)
Figure 38. North America Prescription Arthritis Medications Sales Market Share by Country (2017-2028)
Figure 39. North America Prescription Arthritis Medications Revenue Market Share by Country (2017-2028)
Figure 40. United States Prescription Arthritis Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Prescription Arthritis Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Prescription Arthritis Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Prescription Arthritis Medications Sales Market Share by Type (2017-2028)
Figure 44. Europe Prescription Arthritis Medications Sales Market Share by Application (2017-2028)
Figure 45. Europe Prescription Arthritis Medications Sales Market Share by Country (2017-2028)
Figure 46. Europe Prescription Arthritis Medications Revenue Market Share by Country (2017-2028)
Figure 47. Germany Prescription Arthritis Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Prescription Arthritis Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Prescription Arthritis Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Prescription Arthritis Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Prescription Arthritis Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Prescription Arthritis Medications Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Prescription Arthritis Medications Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Prescription Arthritis Medications Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Prescription Arthritis Medications Revenue Market Share by Region (2017-2028)
Figure 56. China Prescription Arthritis Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Prescription Arthritis Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Prescription Arthritis Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Prescription Arthritis Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Prescription Arthritis Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Prescription Arthritis Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Prescription Arthritis Medications Sales Market Share by Type (2017-2028)
Figure 63. South America Prescription Arthritis Medications Sales Market Share by Application (2017-2028)
Figure 64. South America Prescription Arthritis Medications Sales Market Share by Country (2017-2028)
Figure 65. South America Prescription Arthritis Medications Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Prescription Arthritis Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Prescription Arthritis Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Prescription Arthritis Medications Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Prescription Arthritis Medications Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Prescription Arthritis Medications Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Prescription Arthritis Medications Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Prescription Arthritis Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Prescription Arthritis Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Prescription Arthritis Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Prescription Arthritis Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Prescription Arthritis Medications in 2021
Figure 77. Manufacturing Process Analysis of Prescription Arthritis Medications
Figure 78. Prescription Arthritis Medications Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 関節炎処方薬のグローバル市場展望 2023年-2029年：経口投与、局所投与
  • 世界の皮膚疾患治療薬市場2022年：市場規模予測（～2028年）
  • 世界のOTC鎮痛剤市場2022年：市場規模予測（～2028年）
  • 関節リウマチ治療薬のグローバル市場展望 2023年-2029年：医薬品、バイオ医薬品
  • 関節リウマチ用医薬品のグローバル市場展望 2023年-2029年：医療用医薬品、一般用医薬品
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19563 )"世界の関節炎治療用処方薬市場2022年：市場規模予測（～2028年）" (英文：Global Prescription Arthritis Medications Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。